INDUSTRY PROGRAMME

INDUSTRY
PROGRAMME


 Not yet available.

SATELLITE SYMPOSIA & CONSULT THE EXPERT SESSIONSSCHEDULE OVERVIEWPROGRAMME OVERVIEW

SATELLITE SYMPOSIA & CONSULT THE EXPERT SESSIONS

Satellite Symposia and Consult the Expert sessions will take place during EULAR 2026. These sessions are governed by the EULAR Code of Practice and are strictly prohibited during official scientific programme hours. All industry sessions require approval by EULAR.

To comply with local and European regulations, particularly regarding prescription rights:

  • Participants with a white dot on their EULAR 2026 Congress badge are not permitted to access any industry sessions (Satellite Symposia or Consult the Expert).
  • Exhibitor badges are only valid for entry to the sessions they are organising.

Thank you for adhering to these rules.

Note:

  • Satellite Symposia and Consult the Expert sessions are intended for Delegates entitled to prescribe or supply Prescription-only Medicines (POM).
  • These sessions and their content are independently organised and funded by international pharmaceutical companies, and are separate from EULAR.


SCHEDULE OVERVIEW

WEDNESDAY, 3 JUNE 2026

​

15:45 – 16:15 Consult the Expert 

2 parallel sessions

18:30 – 19:45  Satellite Symposia 

6 parallel sessions

THURSDAY, 4 JUNE 2026

​

09:45 – 10:15 Consult the Expert

3 parallel sessions

12:15 – 13:30  Satellite Symposia

8 parallel sessions

16:15 – 16:45  Consult the Expert

3 parallel sessions

17:30 – 18:45 Satellite Symposia

8 parallel sessions

FRIDAY, 5 JUNE 2026

09:45 – 10:15 Consult the Expert

3 parallel sessions

12:15 – 13:30  Satellite Symposia

8 parallel sessions

16:15 – 16:45  Consult the Expert

2 parallel sessions

17:30 – 18:45 Satellite Symposia

3 parallel sessions


PROGRAMME OVERVIEW


18:30 - 19:45 BST

  • AbbVie - At the Crossroads in RA Care: Navigating Treatment Choices

​Session details

  • Alfasigma - ​Optimising axSpA care: Earlier recognition and better management of disease burden​

​Session details

  • Gedeon Richter - ​Prevention better than treatment: Insights on inflammatory joint disease and osteoporosis

​Session details

  • Johnson & Johnson - Tonight on the EULAR stage: the psoriatic disease spectrum

​Session details

  • MSD - ​Decoding Immune Fibrotic Cross Talk in Rheumatology: From Mechanisms to Decisions​

​Session details

  • UCB and Biogen - ​The Treat-to-Target Balancing Act in SLE Management: Burden, Benefit and Risk​

​Session details


15:45 – 16:15 BST

  • AstraZeneca - ​Achieving disease control early for patients with SLE: why target the IFN pathway?

​Session details

  • MSD - Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions​

​Session details

08:15 - 09:30 (75 mins)

Satellite Symposia
09:30Exhibition opens

09:30 - 10:30 (60 mins)

09:45 - 10:15 (30 mins)

Coffee Break / Exhibition Visit / Poster Viewing and Tours

Meet the EULAR Expert / Consult the Expert 

10:30 - 12:00 (90 mins)

Abstract sessions

12:00 - 13:30 (90 mins)

Lunch & Poster Viewing and Tours

13:30 - 14:45 (75 mins)

Scientific sessions

14:45 - 15:45 (60 mins)

15:00 - 15:30 (30 mins)

Coffee Break / Exhibition Visit / Poster Viewing and Tours

Meet the EULAR Expert / Consult the Expert

15:45 - 17:00 (75 mins)

Scientific sessions

17:00Exhibition Closes
17:30 - 18:45 (75 mins)Satellite Symposia


12:15 – 13:30 BST

  • Alfasigma - Optimising RA treatment in 2026: applying lessons from two decades of therapeutic progress

​Session details

  • AstraZeneca - Time matters: why rapid disease control is the foundation to preventing organ damage in SLE

​Session details

  • Boehringer Ingelheim - ​One patient, one team: tackling autoimmune ILD cases with a rheumatologist, a radiologist and a pulmonologist

​Session details

  • Bristol-Myers Squibb - Autoimmune Disease Trajectories: CAR T Cell Therapy and Perspectives on Immune Reset in SLE and SSc​

​Session details

  • Eli Lilly - ​When Good Treatment Isn’t Enough: Evolving the Standard of Care for Obesity and Psoriatic Disease​

​Session details

  • Medac - New insights into first-line conventional therapies in RA

​Session details

  • Novartis - Shifting Sands in Sjögren’s: Targeting the Disease Activity Beneath the Surface​

​Session details

  • UCB - Mind the Remission GAP in SpA: When Symptoms Say “Fine” but Inflammation Says “Not Yet”

​Session details


17:30 – 18:45 BST

  • Argenx - ​“Guess Who?”: Revealing autoantibodies as hidden drivers of autoimmune rheumatic diseases​

​Session details

  • Biogen - The Evolution of Lupus: Progress, Persistent Burden, and What Comes Next

​Session details

  • Cabaletta Bio - Recent Advances in CAR T Cell Therapy for Autoimmune Diseases

​Session details

  • CSL - Evolving strategies in ANCA-associated vasculitis (GPA/MPA): From clinical trials to real-world practice

​Session details

  • GSK - VEXAS Syndrome: Multidisciplinary Expert Perspectives on Strategies for Patient Care

​Session details

  • Medscape Education Global - The Patient Journey With Severe Refractory Autoimmune Rheumatic Diseases and a Review of the Data on CAR T-Cell Therapies

​Session details

  • Sanofi - ​Practical Implications of Evolving Real-World Evidence and Polymyalgia Rheumatica Guidelines​

​Session details

  • Viatris - ​Advances in understanding SLE: From pathophysiology to future precision care

​Session details


09:45 – 10:15 BST

  • AbbVie - Personalized paths to glucocorticoid-free remission in giant cell arteritis​

​Session details

  • Alexion - An Overview of Hypophosphatasia (HPP)​

​Session details

  • Novartis - Treat-to-target in FMF: Challenging subclinical inflammation​

​Session details

 

16:15 – 16:45 BST

  • Boehringer Ingelheim - Screen, monitor and manage CTD-ILD: practical application of ERS/EULAR guidelines and expert insights

​Session details

  • GSK - Could this be Lupus? Identifying Atypical SLE Manifestations in End-Stage Organ Systems

​Session details

  • UCB - ​Treating WoCBA with SLE: Are We Flying Blind?​

​Session details

08:15 - 09:30 (75 mins)

Satellite Symposia
09:30Exhibition opens

09:30 - 10:30 (60 mins)

09:45 - 10:15 (30 mins)

Coffee Break / Exhibition Visit / Poster Viewing and Tours

Meet the EULAR Expert / Consult the Expert 

10:30 - 12:00 (90 mins)

Abstract sessions

12:00 - 13:30 (90 mins)

Lunch & Poster Viewing and Tours

13:30 - 14:45 (75 mins)

Scientific sessions

14:45 - 15:45 (60 mins)

15:00 - 15:30 (30 mins)

Coffee Break / Exhibition Visit / Poster Viewing and Tours

Meet the EULAR Expert / Consult the Expert

15:45 - 17:00 (75 mins)

Scientific sessions

17:00Exhibition Closes
17:30 - 18:45 (75 mins)Satellite Symposia



12:15 – 13:30 BST

  • AbbVie - ​Improving care in spondyloarthritis: A multidisciplinary approach to the disease and its extra-musculoskeletal manifestations

​ ​Session details

  • AbbVie - Achieving early and accurate diagnosis of axial spondyloarthritis: A case-based discussion​

​Session details

  • Amgen - Targeting CD19+ B-Cells in IgG4-Related Disease: Clinical Evidence and Implications for Long-Term Management​

​Session details

  • Boehringer Ingelheim - ​New dimensions in systemic sclerosis: evolving concepts in diagnosis, prognosis and intervention​

​Session details

  • GSK - Beyond the flare: Acting early in SLE and LN to prevent long-term damage

​Session details

  • Merck - Under the surface: new perspectives in lupus with TLR7/8 inhibition

​Session details

  • Novartis - ​The Grand SpA Debate: Should we target pain or inflammation?​

​Session details

  • UCB - ​Fire and Fragility: The Hidden Bone Burden and Rheumatoid Arthritis

​Session details

 

17:30 – 18:45 BST

  • GSK - Advancing EGPA care: From Timely Recognition to Intervention

​Session details

  • Kyowa Kirin - Shift the trajectory: Why rheumatology management for rare bone diseases, such as XLH, must change

​Session details

  • Vor Bio - ​Upstream Targeting of B Cell Dysregulation to Address the Pathology of Primary Sjögren Disease​

​Session details

09:45 – 10:15 BST

AstraZeneca - ​The benefit of collaboration in SLE: acting early in rheumatology & dermatology

Session details

Eli Lilly - ​Obesity in Psoriatic Arthritis: Mechanisms, Misconceptions, and Management​

Session details

GSK -  EGPA in Focus: What’s Improved, What’s Missing, What’s Next?

Session details


16:15 – 16:45 BST

Alexion - Could It Be Hypophosphatasia (HPP)? A Conversation with the Expert

Session details

GSK - Preventing Progression in Lupus: Are You Intervening Early Enough?

Session details

08:15 - 09:30 (75 mins)

Satellite Symposia
09:30Exhibition opens

09:30 - 10:30 (60 mins)

09:45 - 10:15 (30 mins)

Coffee Break / Exhibition Visit / Poster Viewing and Tours

Meet the EULAR Expert / Consult the Expert 

10:30 - 12:00 (90 mins)

Abstract sessions

12:00 - 13:30 (90 mins)

Lunch & Poster Viewing and Tours

13:30 - 14:45 (75 mins)

Scientific sessions

14:45 - 15:45 (60 mins)

15:00 - 15:30 (30 mins)

Coffee Break / Exhibition Visit / Poster Viewing and Tours

Meet the EULAR Expert / Consult the Expert

15:45 - 17:00 (75 mins)

Scientific sessions

17:00Exhibition Closes
17:30 - 18:45 (75 mins)Satellite Symposia


09:00Exhibition opens
09:00 - 10:15 (75 mins)

Scientific sessions

10:15 - 12:00 (105 mins)

Coffee Break / Exhibition Visit

10:15 - 11:45 (90 mins)

Poster Viewing and Tours

12:00 - 13:15 (75 mins)Scientific sessions
13:15 - 14:45 (90 mins)Highlights session
14:30Exhibition closes


ABSTRACTS